Antiepileptic Drugs (AEDs) Market to see Huge Growth by 2029
Antiepileptic drugs market is anticipated to grow at a significant CAGR during the forecast period. Antiepileptic drugs (AEDs) are commonly known as anticonvulsants or antiseizure drugs. These drugs are used in the treatment of epileptic seizures. Epilepsy is a central neurological disorder that causes brain activity to become abnormal and further causes seizures or periods of unusual behaviour, sensations and sometimes loss of awareness. Additionally, these drugs are also used to stabilize the mood along with the treatment of bipolar disorders or neuropathic pain.
Some major key players in the
market include Abbott Laboratories, GlaxoSmithKline plc, and Pfizer Inc., among
others. The market players are contributing significantly to the growth of the
market by the adoption of various strategies including mergers &
acquisitions, geographical expansion, partnerships and collaborations, and new
product launches, to stay competitive in the market. For instance, in January
2022, Sun Pharmaceutical Industries Ltd. announced the launch of a range of
Brivaracetam dosage forms at an affordable price for epilepsy treatment in
India. Additionally, in June 2021, Glenmark Pharma announced the launch of the
anti-epileptic drug, Rufinamide tablets in the US market. Furthermore, in March
2021, Alkem Laboratories has announced the launch of Brivasure, an affordable
anti-epileptic drug for the treatment of epilepsy in India.
To Request a Sample of our Report on Antiepileptic
Drugs (AEDs) Market: https://www.omrglobal.com/request-sample/antiepileptic-drugs-aeds-market
Market Coverage
•
The market number available for – 2022-2030
•
Base year- 2022
•
Forecast period- 2023-2030
Segment Covered-
·
By Drug Type
Regions Covered-
·
North America
·
Europe
·
Asia-Pacific
·
Rest of the World
Competitive Landscape- Abbott Laboratories, GlaxoSmithKline plc, and Pfizer Inc., among others.
Antiepileptic Drugs Market Report by Segment
By Drug Type
·
First Generation AEDs
·
Phenytoin (Dilantin, Phenytek)
·
Carbamazepine (Carbatrol)
·
Oxycarbazepine (Trileptal)
·
Valproate (Depakote)
·
Others
Second Generation AEDs
·
Lamotrigine (Lamictal)
·
Pregabalin (Lyrica)
·
Rufinamide (Banzel/Inovelon)
·
Levetiracetam (Keppra)
·
Others
A
full Report Antiepileptic Drugs (AEDs) Market is Available @ https://www.omrglobal.com/industry-reports/antiepileptic-drugs-aeds-market
Antiepileptic Drugs Market Report by Region
· United
States
· Canada
Europe
· UK
· Germany
· Spain
· France
· Italy
· Rest
of Europe
Asia-Pacific
· India
· China
· Japan
· South
Korea
· Rest
of APAC
Rest of the World
•
Latin America
•
Middle East & Africa
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
For More Customized Data,
Request for Report Customization @ https://www.omrglobal.com/report-customization/antiepileptic-drugs-aeds-market
About Orion Market Research
Orion Market Research (OMR) is a market research
and consulting company known for its crisp and concise reports. The company is
equipped with an experienced team of analysts and consultants. OMR offers
quality syndicated research reports, customized research reports, consulting
and other research-based services. The company also offer Digital Marketing
services through its
subsidiary OMR Digital and Software development and Consulting Services
through another subsidiary Encanto Technologies.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment